Member Info for PL75

Gormless nonsensical brain rot.

Posted this before... CFO now in place, clinical data continues to impress, the journey continues. Ignore the noise. Happy Friday.

Sell DX, move to Nasdaq, get investment, clear cln, pretend to develop a drug, sell the business for billions. Done

Very well said. Pretty good news for the patients too I'd imagine, pleased for them.

Can't buy a bean on HL.

Nice update today. More to come.

CC works for the shareholders and her job is to maximise value. They have an exit strategy. Watch the Prometheus YouTube vid again if you're hard of thinking.

Posted this before... CFO now in place, the journey has begun.

Sell DX, move to Nasdaq, get investment, clear cln, pretend to develop a drug, sell the business for billions. Done

I brie-leive it's an excellent appointment. I'm grate-ful, he's nacho average CFO

He's a trader. His ramp is to encourage exit liquidity. Good luck.

I wish him the very worst of luck , a thoroughly miserable incompetent lying contemptuous chap 👍

No idea why anyone cares that much about the CFO position, Tony had the job for years so we've effectively not had one for an extremely long time.

They’re saving cash by not having one… CC is a financial genius. I don’t care about Tony Mk2. We’ll not need him until the takeover negotiations start and that’s a little while away. They’ve got plenty bright minds, just ask someone in the lab to get a calculator out to do the accounts.

It was first posted by TTB. Best to not give that arrogant bell any undeserved credit.

But yes, a cracking watch with what will hopefully be many many parallels.

I like this one…. https://www.youtube.com/watch?v=v5kstO1R2vA&ab_channel=StateofMedTech

The avacta sequel will be epic. Sell DX, move to Nasdaq, get investment, clear cln, pretend to develop a drug, sell the business for billions. Done. Everyone’s a winner. Except eggy, who still be invested in a Mongolian dog, prattling in the background about irrelevancies.

Https://www.fda.gov/patients/learn-about-drug-and-device-approvals/fast-track-breakthrough-therapy-accelerated-approval-priority-review

High unmet need is the key part. The FDA love it.

Sorry to bring some data to this guesswork…. Pick your favourite number from the table.

https://clinicaltrialrisk.org/rct-cost-modelling/oncology-trials/?utm_source=chatgpt.com

Can’t and won’t read the usual BS, but the answer to the thread title is in this video. You need a credible threat for the exit strategy.

https://www.youtube.com/watch?v=v5kstO1R2vA&ab_channel=StateofMedTech

Advice? Don’t listen to batsh.t theories, watch this instead.

https://www.youtube.com/watch?v=v5kstO1R2vA&ab_channel=StateofMedTech

PLS, yes, they can buy AIM stocks but they have to wait until the internet is turned on

Thanks for sharing.

It Works (tm)

On the rare occasion his research has gone beyond copy and pasting and talking in the third person I've given some credit, but I've never been a fan. One of the only things I agree with Eggy on. I saw through him very early on. Feel sorry for his victims. There's a lengthy list of dogs he's recommended. He should be honest and just say he's looking for mugs for exit liquidity.

Whilst he says some really stupid stuff, he's not entirely daft and it's obvious there was motivation behind that tweet. Genuine scumbag.